Last reviewed · How we verify
Tinzaparin,Therapeutic anticoagulation — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Tinzaparin,Therapeutic anticoagulation (Tinzaparin,Therapeutic anticoagulation) — Assistance Publique - Hôpitaux de Paris.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Tinzaparin,Therapeutic anticoagulation TARGET | Tinzaparin,Therapeutic anticoagulation | Assistance Publique - Hôpitaux de Paris | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Tinzaparin,Therapeutic anticoagulation CI watch — RSS
- Tinzaparin,Therapeutic anticoagulation CI watch — Atom
- Tinzaparin,Therapeutic anticoagulation CI watch — JSON
- Tinzaparin,Therapeutic anticoagulation alone — RSS
Cite this brief
Drug Landscape (2026). Tinzaparin,Therapeutic anticoagulation — Competitive Intelligence Brief. https://druglandscape.com/ci/tinzaparin-therapeutic-anticoagulation. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab